

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.01921963 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.81160573 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.81160573 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.81160573 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.81160573 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.81160573 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.81160573 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.61304880 |
| 9 | response to peptidoglycan (GO:0032494) | 5.30646926 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.71128125 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.67932002 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.64108318 |
| 13 | neutrophil activation (GO:0042119) | 4.62651970 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.60632377 |
| 15 | detection of bacterium (GO:0016045) | 4.59718738 |
| 16 | detection of external biotic stimulus (GO:0098581) | 4.59492419 |
| 17 | * respiratory burst (GO:0045730) | 4.57250901 |
| 18 | neutrophil mediated immunity (GO:0002446) | 4.50786626 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.50136267 |
| 20 | granulocyte activation (GO:0036230) | 4.49138748 |
| 21 | leukocyte aggregation (GO:0070486) | 4.35197443 |
| 22 | cellular extravasation (GO:0045123) | 4.34909505 |
| 23 | response to host immune response (GO:0052572) | 4.23721642 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.23721642 |
| 25 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.18854110 |
| 26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.17230999 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11956857 |
| 28 | detection of biotic stimulus (GO:0009595) | 4.06660122 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 4.00651918 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 3.98549630 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97814711 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.90208670 |
| 33 | regulation of mast cell activation (GO:0033003) | 3.90047205 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.86913916 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.86706669 |
| 36 | response to host (GO:0075136) | 3.86706669 |
| 37 | response to host defenses (GO:0052200) | 3.86706669 |
| 38 | positive regulation of mast cell activation (GO:0033005) | 3.86176722 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.85503896 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.85383991 |
| 41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.75850964 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.74154676 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.73755605 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 3.69026755 |
| 45 | microglial cell activation (GO:0001774) | 3.66455122 |
| 46 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.62483250 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.62374504 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.62374504 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54705616 |
| 50 | response to fungus (GO:0009620) | 3.51292661 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.51141422 |
| 52 | myeloid leukocyte mediated immunity (GO:0002444) | 3.49060962 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.47006829 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.46788637 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.46788637 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.44739161 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43518595 |
| 58 | response to type I interferon (GO:0034340) | 3.43364651 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.42705313 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41659431 |
| 61 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.41417663 |
| 62 | negative regulation of phagocytosis (GO:0050765) | 3.39066713 |
| 63 | leukocyte mediated cytotoxicity (GO:0001909) | 3.38938385 |
| 64 | macrophage activation (GO:0042116) | 3.38673411 |
| 65 | defense response to protozoan (GO:0042832) | 3.37559453 |
| 66 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.35658637 |
| 67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.35130150 |
| 68 | B cell mediated immunity (GO:0019724) | 3.34027375 |
| 69 | cellular response to zinc ion (GO:0071294) | 3.33882856 |
| 70 | negative regulation of mast cell activation (GO:0033004) | 3.33416666 |
| 71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.32569345 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 3.31882737 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.31723545 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31154488 |
| 75 | response to interleukin-15 (GO:0070672) | 3.29145552 |
| 76 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.26727495 |
| 77 | pinocytosis (GO:0006907) | 3.26061818 |
| 78 | neutrophil chemotaxis (GO:0030593) | 3.25101653 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 3.22979258 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.20466263 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.20466263 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.19895034 |
| 83 | regulation of T cell tolerance induction (GO:0002664) | 3.19814537 |
| 84 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.19808546 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 3.18597765 |
| 86 | * superoxide anion generation (GO:0042554) | 3.16202945 |
| 87 | neutrophil migration (GO:1990266) | 3.15406504 |
| 88 | myeloid leukocyte activation (GO:0002274) | 3.14692946 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10902551 |
| 90 | T-helper 1 type immune response (GO:0042088) | 3.10543825 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.10155319 |
| 92 | response to protozoan (GO:0001562) | 3.07992023 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07155298 |
| 94 | leukocyte degranulation (GO:0043299) | 3.06263802 |
| 95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.06096325 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05021251 |
| 97 | negative regulation of granulocyte differentiation (GO:0030853) | 3.02808743 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 3.02348795 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01415594 |
| 100 | leukotriene metabolic process (GO:0006691) | 3.00677527 |
| 101 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.99053361 |
| 102 | negative regulation of cell killing (GO:0031342) | 2.99053361 |
| 103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97960186 |
| 104 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96605361 |
| 105 | myeloid dendritic cell differentiation (GO:0043011) | 2.96344133 |
| 106 | detection of other organism (GO:0098543) | 2.94909201 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94615965 |
| 108 | positive regulation of interferon-beta production (GO:0032728) | 2.94414594 |
| 109 | cellular response to interleukin-15 (GO:0071350) | 2.94091096 |
| 110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93026987 |
| 111 | negative regulation of growth of symbiont in host (GO:0044130) | 2.91609731 |
| 112 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.91609731 |
| 113 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.91609731 |
| 114 | regulation of growth of symbiont in host (GO:0044126) | 2.91609731 |
| 115 | germinal center formation (GO:0002467) | 2.91566389 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.91293393 |
| 117 | mast cell activation (GO:0045576) | 2.89521881 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89086397 |
| 119 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.87631581 |
| 120 | natural killer cell mediated immunity (GO:0002228) | 2.87631581 |
| 121 | T cell migration (GO:0072678) | 2.87089639 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86130385 |
| 123 | negative regulation of interleukin-17 production (GO:0032700) | 2.85728948 |
| 124 | positive regulation of type 2 immune response (GO:0002830) | 2.84794688 |
| 125 | dendritic cell migration (GO:0036336) | 2.84082816 |
| 126 | regulation of regulated secretory pathway (GO:1903305) | 2.84047638 |
| 127 | actin nucleation (GO:0045010) | 2.83731842 |
| 128 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.80484108 |
| 129 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.80170429 |
| 130 | granulocyte chemotaxis (GO:0071621) | 2.79438962 |
| 131 | leukocyte cell-cell adhesion (GO:0007159) | 2.79210897 |
| 132 | positive regulation of leukocyte degranulation (GO:0043302) | 2.78272501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.12681684 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.98975745 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.60470547 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.27133424 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.16658957 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.10343982 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66348264 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62126400 |
| 9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.61059425 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.36614522 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.32539131 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.18350104 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16586047 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.16205104 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.07952834 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87776308 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.82127922 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73901877 |
| 19 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.57283035 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56699673 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52905521 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41420712 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40074210 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32066795 |
| 25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30724902 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.22641259 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.09820601 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03562071 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03098058 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.01224715 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97468029 |
| 32 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96924595 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95689863 |
| 34 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.88761901 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88428451 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.85594552 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84771757 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.82176039 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.73911174 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72192476 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68630536 |
| 42 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59228251 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55279964 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52711282 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52553506 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52520511 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50090351 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48642798 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46472383 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46419038 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.45295792 |
| 52 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.41687470 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41538256 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40874279 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38595454 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36112776 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35507010 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33483483 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31477359 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29271277 |
| 61 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29232436 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28955148 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26711758 |
| 64 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26269575 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22917361 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21962996 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20993317 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17686031 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17476986 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17388673 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17029224 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16942854 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16692895 |
| 74 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.15820700 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15447197 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14440036 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14144179 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09557032 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08504111 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04200055 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03230636 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01440896 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97936399 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 0.94528992 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94443635 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91958874 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87280470 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83044058 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82302133 |
| 90 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.81410612 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81117931 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80152166 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78909399 |
| 94 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78000059 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76169733 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75875184 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74088853 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73719287 |
| 99 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.72790870 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72233963 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72207030 |
| 102 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71086975 |
| 103 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69825787 |
| 104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68845465 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.64512383 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.63839415 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58499903 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.58477279 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57280179 |
| 110 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.55886607 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.55710093 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.55675791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.46773313 |
| 2 | MP0003436_decreased_susceptibility_to | 3.82754700 |
| 3 | MP0003303_peritoneal_inflammation | 3.72207741 |
| 4 | MP0002419_abnormal_innate_immunity | 3.36989906 |
| 5 | MP0009785_altered_susceptibility_to | 3.19694483 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.06026424 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.98185895 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.91433593 |
| 9 | MP0005025_abnormal_response_to | 2.86192264 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.80849115 |
| 11 | MP0001790_abnormal_immune_system | 2.72839644 |
| 12 | MP0005387_immune_system_phenotype | 2.72839644 |
| 13 | MP0001800_abnormal_humoral_immune | 2.71107600 |
| 14 | MP0000685_abnormal_immune_system | 2.62120986 |
| 15 | MP0005671_abnormal_response_to | 2.59007771 |
| 16 | MP0002723_abnormal_immune_serum | 2.51282096 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.50477123 |
| 18 | MP0001819_abnormal_immune_cell | 2.44763821 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.44415489 |
| 20 | MP0006082_CNS_inflammation | 2.43217613 |
| 21 | MP0003724_increased_susceptibility_to | 2.40629210 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.28030845 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.19190493 |
| 24 | MP0005174_abnormal_tail_pigmentation | 2.06980075 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.06105510 |
| 26 | MP0002405_respiratory_system_inflammati | 2.05089116 |
| 27 | MP0001853_heart_inflammation | 2.02041415 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.98396650 |
| 29 | MP0005451_abnormal_body_composition | 1.93969605 |
| 30 | MP0009278_abnormal_bone_marrow | 1.92940362 |
| 31 | MP0000716_abnormal_immune_system | 1.86240427 |
| 32 | MP0002398_abnormal_bone_marrow | 1.84842684 |
| 33 | MP0004510_myositis | 1.84725810 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.83704565 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.82284634 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.78226956 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.67767632 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.67767632 |
| 39 | MP0000343_altered_response_to | 1.66460334 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.62570377 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.62441683 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.60995815 |
| 43 | MP0002429_abnormal_blood_cell | 1.55654526 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.52286207 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.51347888 |
| 46 | MP0008469_abnormal_protein_level | 1.48822761 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.48569701 |
| 48 | MP0002722_abnormal_immune_system | 1.47892976 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.47143412 |
| 50 | MP0004947_skin_inflammation | 1.46084867 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.45514958 |
| 52 | MP0005310_abnormal_salivary_gland | 1.45512220 |
| 53 | MP0003448_altered_tumor_morphology | 1.43859226 |
| 54 | MP0002006_tumorigenesis | 1.43231020 |
| 55 | MP0009764_decreased_sensitivity_to | 1.43025859 |
| 56 | MP0003075_altered_response_to | 1.41105486 |
| 57 | MP0000858_altered_metastatic_potential | 1.37962063 |
| 58 | MP0001873_stomach_inflammation | 1.32032019 |
| 59 | MP0003828_pulmonary_edema | 1.27298647 |
| 60 | MP0001851_eye_inflammation | 1.27127148 |
| 61 | MP0000490_abnormal_crypts_of | 1.24605774 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.20967292 |
| 63 | MP0010307_abnormal_tumor_latency | 1.20434594 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.15986587 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.14066172 |
| 66 | MP0005166_decreased_susceptibility_to | 1.12803470 |
| 67 | MP0004381_abnormal_hair_follicle | 1.12423928 |
| 68 | MP0008004_abnormal_stomach_pH | 1.09061609 |
| 69 | MP0002933_joint_inflammation | 1.08171455 |
| 70 | MP0009840_abnormal_foam_cell | 1.06959946 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.04608664 |
| 72 | MP0008260_abnormal_autophagy | 0.95144589 |
| 73 | MP0003690_abnormal_glial_cell | 0.93741778 |
| 74 | MP0005390_skeleton_phenotype | 0.93181693 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.92418001 |
| 76 | MP0000371_diluted_coat_color | 0.92061755 |
| 77 | MP0000703_abnormal_thymus_morphology | 0.88362709 |
| 78 | MP0003866_abnormal_defecation | 0.86187618 |
| 79 | MP0002095_abnormal_skin_pigmentation | 0.85049202 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.84261571 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.84101835 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.82730111 |
| 83 | MP0009763_increased_sensitivity_to | 0.81000792 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.79310097 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.77588806 |
| 86 | MP0001663_abnormal_digestive_system | 0.77460297 |
| 87 | MP0005164_abnormal_response_to | 0.77282121 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.76187767 |
| 89 | MP0000604_amyloidosis | 0.75874329 |
| 90 | MP0000249_abnormal_blood_vessel | 0.75082572 |
| 91 | MP0003329_amyloid_beta_deposits | 0.74946962 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74019571 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.73481193 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.72634688 |
| 95 | MP0003091_abnormal_cell_migration | 0.72106315 |
| 96 | MP0008874_decreased_physiological_sensi | 0.69796530 |
| 97 | MP0006054_spinal_hemorrhage | 0.69542309 |
| 98 | MP0004883_abnormal_blood_vessel | 0.67590368 |
| 99 | MP0000920_abnormal_myelination | 0.67378825 |
| 100 | MP0002132_abnormal_respiratory_system | 0.66898872 |
| 101 | MP0003045_fibrosis | 0.66666452 |
| 102 | MP0003795_abnormal_bone_structure | 0.66176695 |
| 103 | MP0002019_abnormal_tumor_incidence | 0.66154391 |
| 104 | MP0003186_abnormal_redox_activity | 0.64051646 |
| 105 | MP0008057_abnormal_DNA_replication | 0.60252983 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.58445985 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.56068455 |
| 108 | MP0004130_abnormal_muscle_cell | 0.55702099 |
| 109 | MP0003693_abnormal_embryo_hatching | 0.54790887 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.53207881 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.50955195 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.50548668 |
| 113 | MP0001958_emphysema | 0.49159632 |
| 114 | MP0002133_abnormal_respiratory_system | 0.48809992 |
| 115 | MP0003279_aneurysm | 0.46536051 |
| 116 | MP0002254_reproductive_system_inflammat | 0.46433600 |
| 117 | MP0008873_increased_physiological_sensi | 0.45861823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 7.44755693 |
| 2 | * Recurrent bacterial skin infections (HP:0005406) | 6.53801154 |
| 3 | * Eczematoid dermatitis (HP:0000976) | 6.11232746 |
| 4 | * Recurrent gram-negative bacterial infections (HP:0005420) | 5.04817962 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.64329174 |
| 6 | * Abnormality of macrophages (HP:0004311) | 4.54264220 |
| 7 | Myositis (HP:0100614) | 4.37878215 |
| 8 | * Recurrent skin infections (HP:0001581) | 4.17469423 |
| 9 | * Mediastinal lymphadenopathy (HP:0100721) | 4.12541237 |
| 10 | * Obstructive lung disease (HP:0006536) | 4.04227042 |
| 11 | * Chronic obstructive pulmonary disease (HP:0006510) | 4.04227042 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.04172365 |
| 13 | * Recurrent fungal infections (HP:0002841) | 4.00260810 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.00122939 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.97896734 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.76184555 |
| 17 | Orchitis (HP:0100796) | 3.73084157 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.63398737 |
| 19 | * Gingivitis (HP:0000230) | 3.59788368 |
| 20 | Optic neuritis (HP:0100653) | 3.56674850 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.56674850 |
| 22 | Recurrent viral infections (HP:0004429) | 3.51477800 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45847444 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45847444 |
| 25 | * Cellulitis (HP:0100658) | 3.44400932 |
| 26 | Stomatitis (HP:0010280) | 3.39642232 |
| 27 | T lymphocytopenia (HP:0005403) | 3.31603151 |
| 28 | * Meningitis (HP:0001287) | 3.26005960 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.24595703 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.24595703 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.24595703 |
| 32 | Dysostosis multiplex (HP:0000943) | 3.24246581 |
| 33 | Periodontitis (HP:0000704) | 3.20914094 |
| 34 | Vasculitis (HP:0002633) | 3.17406606 |
| 35 | Prostate neoplasm (HP:0100787) | 3.15406944 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.14299795 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 3.10525919 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.08907659 |
| 39 | Amyloidosis (HP:0011034) | 3.03009865 |
| 40 | Disinhibition (HP:0000734) | 2.95200844 |
| 41 | IgM deficiency (HP:0002850) | 2.92194124 |
| 42 | Petechiae (HP:0000967) | 2.91318334 |
| 43 | Pustule (HP:0200039) | 2.87707217 |
| 44 | Episodic fever (HP:0001954) | 2.83649598 |
| 45 | Chronic otitis media (HP:0000389) | 2.79992042 |
| 46 | Glomerulonephritis (HP:0000099) | 2.78480213 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.76175653 |
| 48 | Peritonitis (HP:0002586) | 2.73449778 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.73134334 |
| 50 | * Osteomyelitis (HP:0002754) | 2.72238460 |
| 51 | Agnosia (HP:0010524) | 2.72206108 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.71919907 |
| 53 | Anorexia (HP:0002039) | 2.69622484 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66443917 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.66443917 |
| 56 | Pulmonary embolism (HP:0002204) | 2.66424102 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.66190527 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.65762617 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.65605544 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.63907595 |
| 61 | Axonal loss (HP:0003447) | 2.63297449 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.63177764 |
| 63 | Thrombocytosis (HP:0001894) | 2.61246621 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61066310 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61066310 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61066310 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.60701816 |
| 68 | * Recurrent pneumonia (HP:0006532) | 2.60330983 |
| 69 | Leukocytosis (HP:0001974) | 2.58482634 |
| 70 | Basal ganglia calcification (HP:0002135) | 2.57188596 |
| 71 | Gangrene (HP:0100758) | 2.55603106 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.54287886 |
| 73 | Colitis (HP:0002583) | 2.51981869 |
| 74 | Hematochezia (HP:0002573) | 2.49469570 |
| 75 | Increased IgM level (HP:0003496) | 2.49402603 |
| 76 | Arterial thrombosis (HP:0004420) | 2.48800649 |
| 77 | * Urticaria (HP:0001025) | 2.46463376 |
| 78 | Hemoptysis (HP:0002105) | 2.43958570 |
| 79 | Epistaxis (HP:0000421) | 2.42371144 |
| 80 | Abnormality of T cells (HP:0002843) | 2.42290027 |
| 81 | Gingival bleeding (HP:0000225) | 2.41579754 |
| 82 | Hypochromic anemia (HP:0001931) | 2.40796293 |
| 83 | Albinism (HP:0001022) | 2.39200042 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.35672215 |
| 85 | Abnormality of the pleura (HP:0002103) | 2.35345904 |
| 86 | Eosinophilia (HP:0001880) | 2.33272119 |
| 87 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.30987336 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.29263001 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.26660243 |
| 90 | Abnormality of the endocardium (HP:0004306) | 2.23308977 |
| 91 | Loss of speech (HP:0002371) | 2.23029412 |
| 92 | Purpura (HP:0000979) | 2.22110733 |
| 93 | Thoracic kyphosis (HP:0002942) | 2.21303268 |
| 94 | Glomerulopathy (HP:0100820) | 2.20333274 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 2.18047332 |
| 96 | Increased serum ferritin (HP:0003281) | 2.17659739 |
| 97 | Polyneuropathy (HP:0001271) | 2.16868390 |
| 98 | Vertigo (HP:0002321) | 2.15886470 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15883006 |
| 100 | Cheilitis (HP:0100825) | 2.15489626 |
| 101 | Granulocytopenia (HP:0001913) | 2.14024255 |
| 102 | J-shaped sella turcica (HP:0002680) | 2.11794388 |
| 103 | Thyroiditis (HP:0100646) | 2.10629225 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.10605347 |
| 105 | Keratoconjunctivitis (HP:0001096) | 2.09752670 |
| 106 | Panhypogammaglobulinemia (HP:0003139) | 2.09743049 |
| 107 | Encephalitis (HP:0002383) | 2.09437147 |
| 108 | Chest pain (HP:0100749) | 2.07944017 |
| 109 | Increased IgE level (HP:0003212) | 2.07676463 |
| 110 | Slow saccadic eye movements (HP:0000514) | 2.07045529 |
| 111 | Impaired platelet aggregation (HP:0003540) | 2.05949584 |
| 112 | Abnormal platelet function (HP:0011869) | 2.05949584 |
| 113 | Lymphopenia (HP:0001888) | 2.05003252 |
| 114 | Premature loss of primary teeth (HP:0006323) | 2.03966924 |
| 115 | Joint hemorrhage (HP:0005261) | 2.03631655 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02143867 |
| 117 | Acne (HP:0001061) | 2.00899492 |
| 118 | Thick nail (HP:0001805) | 2.00543010 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.99858250 |
| 120 | * Sepsis (HP:0100806) | 1.98394785 |
| 121 | Keratitis (HP:0000491) | 1.98252300 |
| 122 | * Skin ulcer (HP:0200042) | 1.97337178 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.96898834 |
| 124 | Microcytic anemia (HP:0001935) | 1.96732743 |
| 125 | Myocardial infarction (HP:0001658) | 1.96689170 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.94731794 |
| 127 | Amaurosis fugax (HP:0100576) | 1.94378756 |
| 128 | Viral hepatitis (HP:0006562) | 1.93644415 |
| 129 | Abnormality of the thoracic spine (HP:0100711) | 1.90667230 |
| 130 | Hypergammaglobulinemia (HP:0010702) | 1.90080191 |
| 131 | Subacute progressive viral hepatitis (HP:0006572) | 1.89155911 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.87184861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.38064221 |
| 2 | BLK | 3.85707519 |
| 3 | RIPK4 | 3.54604418 |
| 4 | MAP4K1 | 3.41423478 |
| 5 | MAP3K14 | 3.04853268 |
| 6 | IRAK3 | 2.82673247 |
| 7 | KIT | 2.81461443 |
| 8 | TYK2 | 2.50557266 |
| 9 | TBK1 | 2.43722176 |
| 10 | BTK | 2.35737568 |
| 11 | PRPF4B | 2.21490833 |
| 12 | CSF1R | 2.19361596 |
| 13 | TEC | 2.16480366 |
| 14 | TGFBR2 | 2.04854972 |
| 15 | IKBKB | 1.97893719 |
| 16 | TXK | 1.82425507 |
| 17 | IKBKE | 1.80649902 |
| 18 | FES | 1.80418063 |
| 19 | TAOK3 | 1.80211626 |
| 20 | SYK | 1.78028979 |
| 21 | ZAP70 | 1.76588888 |
| 22 | JAK3 | 1.72923125 |
| 23 | TAOK1 | 1.72607031 |
| 24 | HCK | 1.64716687 |
| 25 | ERN1 | 1.64179426 |
| 26 | CSK | 1.62516169 |
| 27 | MAP2K3 | 1.61251587 |
| 28 | CLK1 | 1.59791396 |
| 29 | EPHB1 | 1.53541499 |
| 30 | JAK1 | 1.44097045 |
| 31 | LYN | 1.43503633 |
| 32 | STK10 | 1.43369126 |
| 33 | PIM2 | 1.35349067 |
| 34 | MAP3K1 | 1.31182735 |
| 35 | KSR2 | 1.29162173 |
| 36 | PIM1 | 1.22604372 |
| 37 | IRAK2 | 1.20170185 |
| 38 | MAP3K13 | 1.18291955 |
| 39 | LCK | 1.17699612 |
| 40 | TAOK2 | 1.13287307 |
| 41 | MATK | 1.13159201 |
| 42 | FGR | 1.08654211 |
| 43 | ITK | 1.06313674 |
| 44 | RPS6KA4 | 1.05390935 |
| 45 | TRPM7 | 1.03989251 |
| 46 | CHUK | 1.01959174 |
| 47 | PBK | 1.01551637 |
| 48 | STK4 | 0.98316790 |
| 49 | NEK9 | 0.97536868 |
| 50 | GRK6 | 0.93614983 |
| 51 | YES1 | 0.93389027 |
| 52 | NME2 | 0.91550312 |
| 53 | GRK7 | 0.91414540 |
| 54 | MARK3 | 0.91040378 |
| 55 | JAK2 | 0.86054794 |
| 56 | PDK1 | 0.85787446 |
| 57 | CAMK1D | 0.85747640 |
| 58 | MAP3K2 | 0.85511873 |
| 59 | MARK2 | 0.84112861 |
| 60 | EIF2AK2 | 0.83585396 |
| 61 | PDPK1 | 0.77630531 |
| 62 | CDC42BPA | 0.74310650 |
| 63 | SIK2 | 0.71076304 |
| 64 | MAP3K11 | 0.67784198 |
| 65 | PAK4 | 0.67615973 |
| 66 | LRRK2 | 0.66341957 |
| 67 | FLT3 | 0.64727995 |
| 68 | PRKCD | 0.63213019 |
| 69 | FYN | 0.62933777 |
| 70 | ABL1 | 0.60591367 |
| 71 | RPS6KA6 | 0.60555616 |
| 72 | SIK3 | 0.59378976 |
| 73 | SGK3 | 0.58989451 |
| 74 | MAP3K12 | 0.58423870 |
| 75 | MOS | 0.57248221 |
| 76 | TRIB3 | 0.57226594 |
| 77 | MAPKAPK2 | 0.56051693 |
| 78 | MAP2K4 | 0.55876278 |
| 79 | MAP3K3 | 0.55673606 |
| 80 | FGFR3 | 0.55516971 |
| 81 | KSR1 | 0.55311983 |
| 82 | BMPR2 | 0.55152747 |
| 83 | IRAK1 | 0.54746324 |
| 84 | CDK19 | 0.54527335 |
| 85 | PRKD2 | 0.53954740 |
| 86 | MAPK12 | 0.52510031 |
| 87 | PTK2B | 0.52371414 |
| 88 | CDK6 | 0.52298297 |
| 89 | ABL2 | 0.51824670 |
| 90 | ZAK | 0.50880349 |
| 91 | EPHA3 | 0.49793311 |
| 92 | DAPK2 | 0.49349527 |
| 93 | RPS6KL1 | 0.49344323 |
| 94 | RPS6KC1 | 0.49344323 |
| 95 | EIF2AK3 | 0.49143284 |
| 96 | RAF1 | 0.48909275 |
| 97 | MAPK7 | 0.48762181 |
| 98 | FGFR4 | 0.46812496 |
| 99 | ADRBK2 | 0.46743950 |
| 100 | STK11 | 0.45767309 |
| 101 | DYRK1B | 0.45225972 |
| 102 | EGFR | 0.44921084 |
| 103 | MAPK4 | 0.44742842 |
| 104 | ACVR1B | 0.43484323 |
| 105 | MAP2K6 | 0.42460733 |
| 106 | SGK2 | 0.41555553 |
| 107 | TNK2 | 0.40652461 |
| 108 | HIPK2 | 0.40409204 |
| 109 | RIPK1 | 0.39484423 |
| 110 | SCYL2 | 0.39333631 |
| 111 | PIK3CG | 0.38824877 |
| 112 | MAP3K6 | 0.38739891 |
| 113 | CAMKK1 | 0.38431901 |
| 114 | BMX | 0.35992477 |
| 115 | VRK1 | 0.35962295 |
| 116 | MST4 | 0.35619047 |
| 117 | TESK2 | 0.35241731 |
| 118 | PTK6 | 0.34980936 |
| 119 | TTN | 0.34394456 |
| 120 | MAP3K5 | 0.34232937 |
| 121 | SMG1 | 0.33982439 |
| 122 | RET | 0.33873668 |
| 123 | CAMKK2 | 0.33699307 |
| 124 | CAMK1G | 0.33540745 |
| 125 | PKN2 | 0.31418840 |
| 126 | MAP3K7 | 0.31339394 |
| 127 | NLK | 0.30391755 |
| 128 | NEK2 | 0.29882250 |
| 129 | GRK1 | 0.29533441 |
| 130 | PRKCQ | 0.29484312 |
| 131 | DYRK3 | 0.29388975 |
| 132 | MAP3K10 | 0.29336778 |
| 133 | MAP3K8 | 0.29200109 |
| 134 | CDK9 | 0.28931521 |
| 135 | RPS6KA2 | 0.28579023 |
| 136 | STK24 | 0.28560787 |
| 137 | CDK4 | 0.28125780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.30050017 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.89423954 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.53414950 |
| 4 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52829338 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43992036 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.43370167 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35917102 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27569674 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.25136083 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.22825537 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.17236569 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.12680400 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00080822 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99176305 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.90695764 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89923752 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.89021925 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88914949 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85648580 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75560163 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74188183 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70385390 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.69860627 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61127900 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60898152 |
| 26 | * Phagosome_Homo sapiens_hsa04145 | 1.60781835 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57456356 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.55113911 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53604348 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52416570 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.49975354 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49707267 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.48806446 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47666187 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44326044 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.44312389 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40792422 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.39340496 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38013622 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31164119 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31065259 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20097059 |
| 43 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15965121 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.14788973 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02658256 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01836674 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99030761 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98872318 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97735826 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.94615983 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93364922 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91597940 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83696374 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.82879845 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82688995 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82103192 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81193590 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80716643 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79045562 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75759064 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74102611 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.73992787 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73707468 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72978847 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71053726 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69332619 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67068677 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67032575 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66561377 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66314985 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.61657005 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.61479832 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.59036683 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58454065 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58352837 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55834286 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55068568 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54801289 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54177935 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52716324 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49588142 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49276384 |
| 83 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48917522 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47198660 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46464710 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44794336 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43416865 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42785667 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42311216 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41930716 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41633757 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41567530 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41408893 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41287680 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.40970841 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40578535 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.39710988 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39283307 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38490478 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37831884 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37698408 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37259457 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36859574 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.36260853 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35834093 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33343124 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33051278 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32496915 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31914110 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31235094 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30282259 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30166412 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29497154 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26876988 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26784981 |
| 116 | Mismatch repair_Homo sapiens_hsa03430 | 0.23563174 |
| 117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23480255 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23251859 |
| 119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22948508 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.21274198 |

